Related Experiment Video
Updated: May 21, 2026
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Recent advances in imaging Alzheimer's disease
Meredith N Braskie1, Arthur W Toga, Paul M Thompson
1Laboratory of Neuro Imaging, Department of Neurology, UCLA School of Medicine, Los Angeles, CA 90095-7334, USA.
Journal of Alzheimer'S Disease : JAD
|June 8, 2012
Summary
Recent brain imaging advances significantly improve Alzheimer
Area of Science:
- Neuroimaging
- Alzheimer's Disease Research
- Biomarkers
Background:
- Alzheimer's disease (AD) understanding has been historically limited by diagnostic and monitoring tools.
- Recent technological advancements in neuroimaging offer new avenues for studying AD.
- Early detection and tracking of AD progression are critical for effective intervention.
Purpose of the Study:
- To review recent advancements in brain imaging for Alzheimer's disease (AD).
- To highlight novel methods in amyloid imaging, MRI analysis, and statistical approaches.
- To examine the role of imaging in evaluating AD risk factors, prediction, and progression.
Main Methods:
- Literature review of recent studies in Alzheimer's disease neuroimaging.
- Focus on amyloid imaging, advanced magnetic resonance imaging (MRI) techniques, and statistical modeling.
- Analysis of studies linking risk factors and brain imaging for AD prediction.
Main Results:
- Significant progress in amyloid imaging allows for better visualization of key AD pathology.
- New MRI analysis methods enhance the detection of subtle brain changes associated with AD.
- Integration of risk factor data with imaging provides improved models for AD prediction and progression tracking.
Conclusions:
- Recent neuroimaging innovations are crucial for advancing Alzheimer's disease research.
- These techniques are paving the way for earlier diagnosis and personalized treatment strategies.
- The reviewed studies demonstrate promising new directions in understanding and combating AD.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...